Weigao: climbing the value chain

• Published 20 May 2010

Sales of high-end products helped boost first quarter net profits by over a third from a year earlier.

Background:Shandong Weigao Group Medical Polymer Co (8199:HKG), is based in Shenzhen and focuses on the manufacture of single-use medical devices such as medical tools, as well as products such as syringes, needles, blood bags etc. It sells its products to over 5,400 healthcare organisations and distributors in China and exports to 30 countries.

China Confidential Funds

China Confidential Funds, a new research service launched by FT China Confidential, is dedicated to illuminating the mainland fund industry. Our team of fund industry experts in Shanghai search out the interesting trends in fund performance, strategy, interactions with overseas funds, regulatory changes, distribution and management. We also use a proprietary system to track the emerging flows of Chinese money. Click here to find out more.

Other Articles on this Issue

• Financial China

  Is China headed for a perfect financial storm?

  Select financial charts

• Macro View

  A-share distress

• Consumer China

  Medical devices – in the pink

  Mindray: robust overseas sales

  Beijing Wandong: seeking solace in rural demand

  Shinva: on the acquisition trail

  Lepu: bringing heart technology to lower tier cities

• Funds Data

  China flows go cold

• The Best of Chinese Commentators

  A-share slide

  Falling property prices to hurt local government finances?

• The Big Call

  Real estate prices start to fall

• Capital Intensive China

  Cooling property market to depress steel prices

• Guest Column

  China's new growth model – does it work?

• View issue